CN109170471A - A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage - Google Patents
A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage Download PDFInfo
- Publication number
- CN109170471A CN109170471A CN201811188846.7A CN201811188846A CN109170471A CN 109170471 A CN109170471 A CN 109170471A CN 201811188846 A CN201811188846 A CN 201811188846A CN 109170471 A CN109170471 A CN 109170471A
- Authority
- CN
- China
- Prior art keywords
- orange peel
- dried orange
- solid beverage
- added
- dried
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007787 solid Substances 0.000 title claims abstract description 20
- 235000013361 beverage Nutrition 0.000 title claims abstract description 16
- 240000000588 Hericium erinaceus Species 0.000 title claims abstract description 14
- 235000007328 Hericium erinaceus Nutrition 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 65
- 235000019441 ethanol Nutrition 0.000 claims abstract description 36
- 241000289669 Erinaceus europaeus Species 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 16
- 241000233866 Fungi Species 0.000 claims abstract description 14
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 239000000706 filtrate Substances 0.000 claims abstract description 11
- 238000010992 reflux Methods 0.000 claims abstract description 9
- 238000005550 wet granulation Methods 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims description 32
- 229920002774 Maltodextrin Polymers 0.000 claims description 18
- 239000005913 Maltodextrin Substances 0.000 claims description 18
- 229940035034 maltodextrin Drugs 0.000 claims description 18
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 10
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- 239000008101 lactose Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 abstract description 21
- 229920001282 polysaccharide Polymers 0.000 abstract description 21
- 239000005017 polysaccharide Substances 0.000 abstract description 21
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 8
- 235000020985 whole grains Nutrition 0.000 abstract description 5
- 241000123222 Hericium Species 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 4
- 235000009508 confectionery Nutrition 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 230000000050 nutritive effect Effects 0.000 abstract description 3
- 230000004206 stomach function Effects 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 229960004756 ethanol Drugs 0.000 abstract 2
- 239000000284 extract Substances 0.000 description 21
- 239000002245 particle Substances 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 4
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 4
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 4
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 4
- 239000006286 aqueous extract Substances 0.000 description 4
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 3
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 3
- 206010056474 Erythrosis Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 241000577951 Hydnum Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011122 softwood Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000011172 small scale experimental method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage, making step is as follows, and hedgehog fungus mycelium is broken into fritter first, fingered citron and dried orange peel is added, filtrate is extracted through alcohol reflux, filtrate is concentrated and dried to obtain medicinal powder, solid powder is finally made by whole grain and ethyl alcohol wet granulation in medicinal powder.Advantages of the present invention: full side is made of hedgehog fungus mycelium, fingered citron and dried orange peel.We reuse hericium mycelium; it is a kind of common food with health care function; it is sweet natured; there are relieving the five internal organs, aid digestion, the effect of nourishing the body, has the function of stomach function and protecting, by using ethanol refluxing process; the effective components such as polysaccharide, the aurantiamarin in medicinal material are extracted; solid beverage is made, easy to use, nutritive value is high.
Description
Technical field
The present invention relates to healthcare products fields, and in particular to a kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage.
Background technique
Hericium erinaceus is russule mesh hedgehog hydnum Cordycepps Hericium erinaceus Hericium erinaceus (Rull ex F.) Pers., belongs to load
Daughter bacteria guiding principle is a kind of saprophytic bacteria, and a kind of famous edible mushroom.Holotype is commonly called as Hericium erinaceus or monkey mushroom like hedgehog or hedgehog hydnum.
Hericium erinaceus is mild-natured, sweet in flavor, have effects that relieving the five internal organs, aid digestion, nourishing, anticancer, treatment neurasthenia, for anorexia and loose stool,
Gastric and duodenal ulcer, neurasthenia, cancer of the esophagus, gastric cancer, dizziness, impotence etc..Hedgehog fungus mycelium mainly contains polysaccharide, egg
White, polypeptide and oleanolic acid constituents, main active are polysaccharide, and " Chinese Pharmacopoeia " version Chinese medicine material in 2015
It is one of quality control index ingredient that polysaccharide is also selected in amount control.
Hericium mycelium is chiefly used in making the extraction of health care product or polysaccharide, is directly used in fewer in terms of food.
Summary of the invention
To solve the above problems, the present invention provides a kind of nutritive value height, there is health care, enhancing immunity of organisms effect
The manufacture craft of Hericium erinaceus dried orange peel solid beverage.
Technical solution is as follows: the Hericium erinaceus dried orange peel solid beverage is made of the following components:
Every 1000g solid beverage includes, hedgehog fungus mycelium 540g, fingered citron 180g, dried orange peel 180g, maltodextrin 180g, erythrose
Alcohol 240g and lactose 400g；
The making step is as follows: hedgehog fungus mycelium (1) being broken into the fritter of 1cm, fingered citron and dried orange peel is then added, is mixed
Close medicinal material；
(2) 30% ethyl alcohol of mixing six times of quality of medicinal material is then added, refluxing extraction 2 times, 1.5 hours every time, then filters, passes through
The screening of 200 mesh screens, obtains filtrate；
(3) by filtrate at 70 DEG C, -0.09Mpa is concentrated under reduced pressure into the thick paste of relative density 1.30-1.4；
(4) 400 g of lactose is added into thick paste, mixes, 70 DEG C, -0.09Mpa is dried under reduced pressure, and is taken out, and is crushed, and 40 meshes are crossed；
(5) 180 g of maltodextrin and 240 g of antierythrite is added, total amount is adjusted to 1000g with maltodextrin, is mixed, with 80%
Ethyl alcohol wet granulation；
(6) powder obtained is dried into 2h at 60 DEG C, is screened through 16 meshes；
(7) it packs.
Advantages of the present invention: full side is made of hedgehog fungus mycelium, fingered citron and dried orange peel.We reuse hericium mycelium, are
A kind of common food with health care function, it is sweet natured, there are relieving the five internal organs, aid digestion, the effect of nourishing the body, there is stomach function
The effect that can be protected.Fingered citron liver-smoothing, qi-regulating, protecting the stomach and relieve the pain, have stagnation of liver-QI and stomach-QI, distending pain in the chest and hypochondrium, gastral cavilty feeling of fullness, deficiency of food vomiting
Effect；Dried orange peel has regulating QI and lowering the adverseness, appetizing, eliminating dampness and eliminating phlegm function in tune, have taste retention of dampness due to stagnation of QI, chest and diaphragm expire vexed, abdominal distention,
The effects of do not feel like eating, dirty inverse vomiting, enhance the effect of the stomach function and protecting of hericium mycelium.By using alcohol reflux
Method has extracted the effective components such as polysaccharide, the aurantiamarin in medicinal material, solid beverage is made, easy to use, and nutritive value is high.
Specific embodiment
A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage, which is characterized in that
The Hericium erinaceus dried orange peel solid beverage is made of the following components:
Every 1000g solid beverage includes, hedgehog fungus mycelium 540g, fingered citron 180g, dried orange peel 180g, maltodextrin 180g, erythrose
Alcohol 240g and lactose 400g；
The making step is as follows: hedgehog fungus mycelium (1) being broken into the fritter of 1cm, fingered citron and dried orange peel is then added, is mixed
Close medicinal material；
(2) 30% ethyl alcohol of mixing six times of quality of medicinal material is then added, refluxing extraction 2 times, 1.5 hours every time, then filters, passes through
The screening of 200 mesh screens, obtains filtrate；
(3) by filtrate at 70 DEG C, -0.09Mpa is concentrated under reduced pressure into the thick paste of relative density 1.30-1.4；
(4) 400 g of lactose is added into thick paste, mixes, 70 DEG C, -0.09Mpa is dried under reduced pressure, and is taken out, and is crushed, and 40 meshes are crossed；
(5) 180 g of maltodextrin and 240 g of antierythrite is added, total amount is adjusted to 1000g with maltodextrin, is mixed, with 80%
Ethyl alcohol wet granulation；
(6) powder obtained is dried into 2h at 60 DEG C, is screened through 16 meshes；
(7) it packs.
Research process:
1. Extraction solvent is investigated
Extracting method: taking 18 g of hedgehog fungus mycelium fritter, dried orange peel silk and each 6 g of finger citron sliced, mixes, parallel four parts, respectively plus 5 times
Water, 30% ethyl alcohol, 50% ethyl alcohol and 80% ethyl alcohol are measured, is heated to reflux 2 times, 1.5 hours every time, filtering, merging filtrate to 250 ml held
In measuring bottle, add coordinative solvent to scale, it is spare.
Sample ergosterol is as follows containing result is surveyed:
Sample polysaccharide determination result is as follows:
Sample the rate of extract measurement result is as follows:
Content of hesperidin measurement is as follows in extracting solution:
Conclusion: ergosterol is not detected ergosterol under this chromatographic condition in 30%Et and aqueous extract, in 80%Et extracting solution
Quantitative Determination of Ergosterol highest, the rate of transform are about 22%；Content highest in polysaccharide aqueous extract, polysaccharide is slightly lower in 30%Et extracting solution,
It is minimum in 80%Et extracting solution；It is most that extract aqueous extract obtains cream, and it is close with aqueous extract that 30%Et obtains cream, 80%Et extracting solution
It is minimum to obtain cream；Aurantiamarin 30%Et and 50%Et extracts content of hesperidin, and there was no significant difference, and 80%Et extraction is slightly higher, and water extracts most
It is low.Comprehensively considering hedgehog fungus mycelium principle active component is polysaccharide, therefore combination polysaccharide, aurantiamarin extracted amount and extract content,
The factors such as ethyl alcohol cost select 30% ethyl alcohol as Extraction solvent.
2 solvent usages are investigated
Extracting method: select 30% ethyl alcohol as Extraction solvent, using polysaccharide, extract and aurantiamarin as index, fixed extraction time
It is 1.5 hours, extraction time is 2 times, investigates influence of 4,6, the 8 different liquid-to-solid ratios to polysaccharide, extract and aurantiamarin respectively.
Said extracted liquid is taken, is measured, it is as follows that solvent usage investigates measurement result:
Conclusion: the experimental results showed that, polysaccharide, extract and the aurantiamarin of 6 times of amount solvent extractions are above 4 times of amounts, 8 times of amount solvents
Polysaccharide, extract and the aurantiamarin of extraction are slightly above 4 times of amounts, consider production cost, determine and use 6 times of amount solvent extractions.
3 extraction times were investigated
Extracting method: fixed liquid-to-solid ratio is 6, and extraction time is 2 times, investigate respectively 1,1.5,2 h different extraction times to polysaccharide,
The influence of extract and aurantiamarin.
Said extracted liquid is taken, is measured, it is as follows that extraction time investigates measurement result:
Conclusion: the experimental results showed that, it extracts polysaccharide, extract and the aurantiamarin that 1.5 h times extracted and is above 1 h's of extraction
Amount, extract 2 h polysaccharide, extract and aurantiamarin and extract 1.5 h amount there was no significant difference, consider production cost, determine
Using 1.5 h extraction times.
4 extraction times are investigated
Extracting method: fixed liquid-to-solid ratio is 8, and extraction time is 1.5 hours, investigate respectively 1,2,3 different extraction times to polysaccharide,
The influence of extract and aurantiamarin.
Said extracted liquid is taken, is measured, it is as follows that extraction time investigates measurement result:
Conclusion: the experimental results showed that, extracting 2 polysaccharide, extract and aurantiamarins extracted altogether is respectively to extract 3 times
95.45%, 93.93% and 95.08%, consider production cost, determines using extraction 2 times.
The verifying of 5 extraction processes
Extracting method: stability and reliability in order to investigate preferably rear extraction process, it is determining most by single factor exploration test
Good technique amplifies 10 times, repeats 3 scale-ups.
3 batches of extraction process amplification test measurement results are as follows:
Conclusion: the experimental results showed that, 3 parts of tests, polysaccharide, extract and aurantiamarin extracted amount are more uniform, and extraction process repeats
Property it is good, the mean transferred rate of aurantiamarin is 75.69%, the results showed that, this extraction process is feasible.
6 extraction processes, which are investigated, to be summarized
In conclusion the extraction process of this product are as follows: hedgehog fungus mycelium is taken to be crushed (about 1cm fritter), fingered citron (thin slice medicine materical crude slice), dried orange peel
(medicine materical crude slice, chopping) is spare.Hedgehog fungus mycelium, fingered citron and dried orange peel are weighed by recipe quantity, 6 times of 30% ethyl alcohol of amount are added are heated to reflux and mention
It takes twice, 1.5 hours every time, the filtration of 200 meshes, merging filtrate.
7 concentration technologies are investigated
3 parts of extracting solutions are merged into (10 times of amount prescription medicine verification test extracting solutions), stirs evenly, is divided into 3 parts, depressurize respectively dense
(70 DEG C) are contracted to different degrees of, and glutinous wall phenomenon is observed after no alcohol taste, measures its relative density.
It is as follows that concentrating degree investigates result:
Using reduced pressure, it is condensed into three concentration relative densities in table 11 respectively, relative density is small very dilute in view of that can use phase
Sticking wall area to many auxiliary materials, when relative density is larger is about in the 10% of bottom of bottle.It is sufficiently mixed for the ease of extracting solution and lactose
It closes, forms uniformity dried cream powder, be conducive to preparations shaping, it is 1.30~1.40(70 that said extracted solution, which is concentrated into relative density,
DEG C) thick paste, be dried under reduced pressure into dried cream powder.
8. the research of preparation process
The selection of 8.1 dosage forms
According to the property of composition flavour of a drug, and our the characteristics of being used as food, dosage form of the granule as this product is selected, it is main
Reason is wanted to have the following aspects:
1) our taking dose is larger, convenient to take as food suitable for granule is made, and is to be easier to received dosage form；
2) granule production operation is simple, have it is easy to use, product stability is good, divided dose is accurate, medicament contg difference compared with
The advantages that small, maximum composition for retaining original soup agent [14-15].
Therefore, granule is made in we, as foods solid beverage, makes to take after mixing it with hot water, not only maintain decoction
Characteristic, and retain the composition of original soup agent, facilitate patients.
8.2 Study on Forming
8.2.1 the selection of diluent
According to the property of dry extract and the sweet taste of food, suitable diluent, corrigent and adhesive need to be added and be conducive to
The molding of particle.Experience, this test selective extraction object dried cream powder and auxiliary material (maltodextrin, red moss are researched and developed according to seminar's early period
Sugar alcohol, maltodextrin: antierythrite=3: 3, antierythrite, maltodextrin: antierythrite=3: 4, maltodextrin: erythrose
Alcohol=3: 5) being sufficiently mixed, and suitable softwood is made with 80% ethyl alcohol, and granulation, dry (60 DEG C), whole grain is up to particle.
It is as follows that result is investigated in auxiliary material selection:
Pelletized according to the first auxiliary material of upper table, there are many fine powders in discovery, the above two moisture be greater than it is 8% undesirable, the
3 and 5 kind of hardness it is larger；Ratio of briquetting, inspection of foreign substance, heap density, hydroscopicity and the angle of repose etc. of granules of accessories are determined, is carried out comprehensive
Evaluation is closed, selects maltodextrin: antierythrite=3: 4 auxiliary material as this product particle preparation.
8.2.2 the selection of adhesive
We compare adhesive using single factor experiment method, have investigated 70% ethyl alcohol, 80% ethyl alcohol, 90% ethyl alcohol respectively
Granulation situation, concrete operations are as follows:
It takes dry extract appropriate, parallel 3 parts, respectively using 70% ethyl alcohol, 80% ethyl alcohol, 90% ethyl alcohol as adhesive, stirs and evenly mixs, make
At softwood, 16 mesh screens were squeezed, record the molding phenomenon of preparation, the investigation of adhesive is as follows in wet-granulation process:
The experimental results showed that the granulating efficiency using 80% ethyl alcohol as adhesive compared with 70% ethyl alcohol, 90% ethyl alcohol is good, therefore select 80%
Adhesive of the ethyl alcohol as wet granulation.
8.2.3 whole grain
By particle obtained in 60 DEG C of low temperature forced air dryings, not only dry particle but also effective component can be utmostly protected.It is dry
Particle afterwards crosses 16 mesh sieves, and fine powder and particle are sufficiently mixed uniformly.
8.3 moulding process are summarized
Groped by laboratory, comparative studies, determine this product moulding process are as follows: recipe quantity medicinal material extract dried cream powder (is added into 400 g
Lactose), 180 g of maltodextrin and 240 g of antierythrite is added, total amount is adjusted to 1000g with maltodextrin, is mixed, with 80% second
Alcohol wet granulation, 60 DEG C of oven dryings, whole grain, be made 1000 g particles to get.
9. process certification
According to preferably after extraction process and preparation process, complete three batches of lab scale sample preparations:
The medicinal material of 1 recipe quantity is taken, parallel 3 points, 6 times of 30% ethyl alcohol heating and refluxing extractions of amount are added twice, 1.5 hours every time,
200 meshes filtration, merging filtrate, ethyl alcohol is recovered under reduced pressure and be concentrated into relative density be 1.30~1.40(70 DEG C) thick paste, take
400 g of lactose is added in thick paste, mixes, and is dried under reduced pressure (temperature is no more than 70 DEG C), takes out, crushes, spare.Dried cream powder is taken to be added
240 g of 180 g of maltodextrin and antierythrite adjusts total amount to 1000g with maltodextrin, mixes, with 80% ethyl alcohol wet process system
Grain, 60 DEG C of oven dryings, whole grain, be made 1000 g particles to get.
Three batches of lab scale sample datas are as follows:
According to known to upper table data: three batches of small-scale experiment yield rates are to be all larger than 95%, it was demonstrated that the production technology is basicly stable.
Claims (1)
1. a kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage, which is characterized in that the Hericium erinaceus dried orange peel solid beverage by with
Lower component composition: every 1000g solid beverage includes, hedgehog fungus mycelium 540g, fingered citron 180g, dried orange peel 180g, maltodextrin
180g, antierythrite 240g and lactose 400g；
The making step is as follows: hedgehog fungus mycelium (1) being broken into the fritter of 1cm, fingered citron and dried orange peel is then added, is mixed
Close medicinal material；
(2) 30% ethyl alcohol of mixing six times of quality of medicinal material is then added, refluxing extraction 2 times, 1.5 hours every time, then filters, passes through
The screening of 200 mesh screens, obtains filtrate；
(3) by filtrate at 70 DEG C, -0.09Mpa is concentrated under reduced pressure into the thick paste of relative density 1.30-1.4；
(4) lactose 400g is added into thick paste, mixes, 70 DEG C, -0.09Mpa is dried under reduced pressure, and is taken out, and is crushed, and 40 meshes are crossed；
(5) maltodextrin 180g and antierythrite 240g is added, total amount is adjusted to 1000g with maltodextrin, is mixed, with 80% second
Alcohol wet granulation；
(6) powder obtained is dried into 2h at 60 DEG C, is screened through 16 meshes；
(7) it packs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811188846.7A CN109170471A (en) | 2018-10-12 | 2018-10-12 | A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811188846.7A CN109170471A (en) | 2018-10-12 | 2018-10-12 | A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109170471A true CN109170471A (en) | 2019-01-11 |
Family
ID=64948237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811188846.7A Pending CN109170471A (en) | 2018-10-12 | 2018-10-12 | A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109170471A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112401093A (en) * | 2020-11-21 | 2021-02-26 | 广东轻工职业技术学院 | Functional beverage capable of nourishing and protecting stomach and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040029955A1 (en) * | 2002-05-15 | 2004-02-12 | Takashi Kouge | Composition for use in prevention or treatment of vascular-related diseases |
| US20060280753A1 (en) * | 2005-06-11 | 2006-12-14 | Mcneary Peter | Composition and Method For Obtaining A Nutritional Food Product Using Solid Substrate Fermentation |
| CN103478792A (en) * | 2013-09-25 | 2014-01-01 | 中恩（天津）医药科技有限公司 | Solid beverage for improving gastrointestinal function and preparation method thereof |
| CN105146663A (en) * | 2015-09-24 | 2015-12-16 | 南陵县石斛产业协会 | Method for preparing hericium erinaceus solid beverage |
-
2018
- 2018-10-12 CN CN201811188846.7A patent/CN109170471A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040029955A1 (en) * | 2002-05-15 | 2004-02-12 | Takashi Kouge | Composition for use in prevention or treatment of vascular-related diseases |
| US20060280753A1 (en) * | 2005-06-11 | 2006-12-14 | Mcneary Peter | Composition and Method For Obtaining A Nutritional Food Product Using Solid Substrate Fermentation |
| CN103478792A (en) * | 2013-09-25 | 2014-01-01 | 中恩（天津）医药科技有限公司 | Solid beverage for improving gastrointestinal function and preparation method thereof |
| CN105146663A (en) * | 2015-09-24 | 2015-12-16 | 南陵县石斛产业协会 | Method for preparing hericium erinaceus solid beverage |
Non-Patent Citations (1)
| Title |
|---|
| 刁治民等编著: "《食用菌学》", 31 August 2006, 青海人民出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112401093A (en) * | 2020-11-21 | 2021-02-26 | 广东轻工职业技术学院 | Functional beverage capable of nourishing and protecting stomach and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101850074B (en) | Method for preparing Chinese patent medicament medicated leaven | |
| CN102274477A (en) | Sugar-free granules for treating wind-cold type common cold and preparation method thereof | |
| CN105663444B (en) | Compound immunity enhancing and anti-aging agent and preparation method thereof | |
| CN108355047A (en) | A kind of preparation process of lilii and Rehmanniae Decoction solid pharmaceutical preparation | |
| CN103394045B (en) | Chinese medicine composition and preparation method and application thereof | |
| CN102823672B (en) | A kind of puer tea composition for adjusting blood fat | |
| CN109170471A (en) | A kind of manufacture craft of Hericium erinaceus dried orange peel solid beverage | |
| CN103919051B (en) | A kind of matrimony vine oatmeal with blood sugar reducing function and preparation method thereof | |
| CN105106816A (en) | Traditional Chinese medicine healthcare preparation with protection effect on chemical liver injury and preparing method thereof | |
| CN112516219B (en) | Preparation process of traditional Chinese medicine granules for treating systemic lupus erythematosus | |
| CN102266503A (en) | Sugar-free anemopyretic cold granules and preparation method thereof | |
| CN102058099A (en) | Health care food for losing weight | |
| CN100408063C (en) | Effervescent tablet for treating infant diarrhea | |
| CN104225163B (en) | It is a kind of to treat pharmaceutical composition of alpastic anemia and its preparation method and application | |
| CN107173805B (en) | Health food with function of preventing and treating lung cancer | |
| CN110269920A (en) | Alleviate the Traditional Chinese drug mixture and preparation method thereof of stomach disease | |
| CN106309809B (en) | Qingxin Shenan granule and preparation method thereof | |
| CN105145957B (en) | A kind of health-care herbal tea beverage improving oral ulcer and preparation method thereof and detection method | |
| CN108619314A (en) | A kind of preparation method of Chinese medicinal granule object | |
| CN104352940B (en) | A kind of Chinese medicine composition for alleviating physical fatigue | |
| CN104126786B (en) | A kind of health product improving high glucose and high fat and preparation method thereof | |
| CN104127816B (en) | A kind of pharmaceutical composition for treating diabetes and its production and use | |
| CN102441135A (en) | Traditional Chinese medicine for treating lung cancer and stomach cancer, its preparation method and quality control technology | |
| CN108478752A (en) | A kind of integration of drinking and medicinal herbs Chinese medicine composition and preparation method improving insomnia | |
| CN101869644A (en) | Dark-skinned chicken dispersible tablet and preparation process thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190111 |
|
| WD01 | Invention patent application deemed withdrawn after publication |